At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential

A Jurj1, D Qian2, G A Calin3

  • 1Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; The Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj Napoca, Romania.

Abstract

No abstract available in PubMed .